Work

PS5-09-10: A randomized phase II study comparing monthly versus 3-monthly GnRH agonist for ovarian function suppression in premenopausal patients with HR-positive breast cancer: study design and rationale

Year: 2026

Type: article

Study design: Study Protocol

Source: Clinical Cancer Research

DOI: 10.1158/1557-3265.sabcs25-ps5-09-10

Authors: D. Audi Blotta, Y. Chen, A. Buzaid, M. Robson

Institutions: Memorial Sloan Kettering Cancer Center, Beneficência Portuguesa de São Paulo

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7129365459

FWCI:

Cites:

Cited by:

Related to: